Breaking News

You are here » Indian-Commodity  :  Commodities  :  Pepper  :  Pepper futures trade higher on NCDEX

21-Mar2013

Pepper futures trade higher on NCDEX

Pepper futures traded up as speculators enlarged their position on spot demand. However, expectations of a higher output this year and weak exports have capped the gains.

The contract for April delivery was trading at Rs 35600.00, up by 0.44% or Rs 155.00 from its previous closing of Rs 35445.00. The open interest of the contract stood at 1344 lots.

The contract for May delivery was trading at Rs 35400.00, up by 0.25% or Rs 90.00 from its previous closing of Rs 35310.00. The open interest of the contract stood at 962 lots on NCDEX.


Related News

View all news

Government imposes MIP on pepper at Rs 500 per kg

The Centre has imposed a Minimum Import Price (MIP) on pepper at Rs 500 per kg. The commerce ministry said it has set the MIP on pepper at Rs 500 per kg as proposed by the Spices Board in order to protect......

MCX launches trading in Malabar Garbled Black Pepper futures

Multi Commodity Exchange of India (MCX), India's No. 1 commodity exchange, has launched trading in Malabar Garbled Black Pepper futures contract on July 24, 2017. This step has been taken by the exchange......

NCME modifies, re-activates pepper futures contracts

The National Multi Commodity Exchange of India (NCME) has incorporated modification in its pepper futures contracts and is going to reactivate pepper contract. All the existing running contracts of Pepper......

Top News

View all news

Bhansali Engineering Polymers reports 33% fall in Q2 net profit

Bhansali Engineering Polymers has reported results for second quarter ended September 30, 2018.The company has reported 32.71% fall in its net profit at Rs 16.89 crore for the quarter under review as compared......

Biocon, Mylan N.V. receive positive CHMP opinion for Ogivri

Biocon and Mylan N.V. have announced that the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion recommending approval of Ogivri, a biosimilar......

Lupin Neurosciences receives positive CHMP opinion for NaMuscla

Lupin Neurosciences, a specialty pharma division of Lupin has announced that the Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMA),......